Prostate cancer incidence and disease-specific survival of men with initial prostate-specific antigen less than 3.0 ng/ml who are participating in ERSPC Rotterdam.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples